證據來源 · Source

EMA semaglutide 與 NAION 結論

https://www.ema.europa.eu/en/news/prac-concludes-eye-condition-naion-very-rare-side-effect-semaglutide-medicines-ozempic-rybelsus-wegovy

← 回知識庫首頁